| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Leading Into the Future |
|
Digg It - Leading Into the Future
The subject of leadership goes to the root of organized human behavior. Leadership is so integral to who we are that it's difficult to imagine human history without it. Would great cities hav According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product e ever been built without it? Would nations have been forged? Indeed, could any great endeavor have been accomplished without leadership? Very likely, no. It is little wonder, then, that lea ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in dership continues to be a very high priority in modern organizations and promises to remain one into the foreseeable future. The Human Resource Institute's 2003-2004 Major Issues Survey found, lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. for example, that among North American companies ranking 120 different issues, leadership was viewed as the single most important one in terms of its impact on workforce management. Among Eur here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe opean companies, it was ranked third. This isn't a new development. Since 1988, when HRI began conducting its major issues surveys of many of the top companies in the world, leadership has be d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro en ranked among the top five issues. Since 1997, leadership has always taken the top spot. In the most recent survey, fully 76% of North American respondents said it was extremely important; t ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc he highest percentage in the history of these surveys (Human Resource Institute, 2004a). Equally important, leadership is expected to remain a top issue in the future. When asked to predict t easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi he importance of various issues ten years into the future, North Americans and Europeans again rated leadership first and third, respectively. But leaders don't spring into the world fully for nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically med. They need to be trained and developed, whatever their natural talents. This isn't lost on today's organizations. Training magazine's 2005 survey of senior training professionals included and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ leadership and management development as the top training priorities for 2005 (Hall, 2005). Another survey, this one conducted by Right Management Consultants for the 2004 World Business For ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi um (Marcus, 2004), found that 65% of surveyed firms placed leadership development as one of the top five focal points for ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a corporate strategy. This response was 20% higher than responses to a similar study conducted just eight years prior. In this report, we take an in-depth look at the subject of leadership, the dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod roles leaders are playing in today's organizations, and how the best-in-class organizations develop them. We also look into the future to see how leadership may change over the next decade or cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin so. The following page is a quick review of some of our findings: - Organizational leadership, which has always been a challenging task, has become even more stressful and difficult in recen tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen t years. - Leadership has grown in importance due to the fast pace of change in combination with increased global competition and a growing focus on the customer. - Today's leaders a t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel re expected to be excellent strategists and communicators. - Business ethics will become more not less important to leadership over the next ten years. - If they don't perform well, ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust top leaders of major companies can expect to lose their jobs more quickly than ever before. - Even while making sure their companies performs well, leaders are expected to develop other l y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products eaders. - Technology and new organizational structures are changing the ways leaders do their jobs. - Leaders must increasingly balance managerial control with the need to spark inno . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de vation in their organizations. - The top barrier to leadership development is a lack of behavior measures, followed by inadequate content in development programs. - When it comes to elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip leadership, most companies know what's important but don't always act on this knowledge. - Best-in-class companies are committed and unremitting in their pursuit of leadership excellence. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Convention Event Planning Service Guidelines Flexibility As a Criteria for Information Systems Building Great Customer Experiences - Or Beware Consultants With No Clothes!
|